Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Make-or-Break Canada Day Weekend Set to Deliver 30%+ Boost for Canada’s Bar and Restaurant Owners
-
AdaCore and CodeSecure Merge to Form a Global Company Providing Embedded Software Security and Safety Solutions
-
Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate
-
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China
-
Biocellis and General Inception announce equity partnership and strategic collaboration with Institut Pasteur.
-
Central Ossington Opens July 3 – Toronto’s Newest Spot for Food, Cocktails, and Culture
-
A.I.S. Resources Closes Shares for Debt Transaction
-
HotSpot Therapeutics to Present Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025
-
I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025
-
Intelliseq Integrates Genomenon's Cancer Knowledgebase (CKB) into iFlow Platform to Advance Somatic Variant Interpretation
-
Mill Creek Announces Start of Preleasing at Modera University Park
-
Roundhill Investments Launches Five New WeeklyPay™ ETFs
-
THE COUNTDOWN IS ON: TWO WEEKS TO GO UNTIL HUBLOT STARTS THE CLOCK ON UEFA WOMEN'S EURO 2025™
-
Molly Baz's Ayoh Raises $4.5M, Launches at Whole Foods Market Nationwide
-
KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS
-
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care
-
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
-
Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, July 10, 2025
-
Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) Investor Webinar with Presentation and Audience Q&A
-
Univar Solutions and Ingredion Expand Functional Food and Beverage Ingredients Partnership to Benelux Region
-
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer
-
Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss
-
DNS4EU Goes Live, Confirming Strength of Brno's Cybersecurity Ecosystem, Says Innovation Agency JIC
-
Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
-
Tillman Fiber Appoints Ed Chan as CEO to lead Fiber-to-the-Home Network Buildout Across the State of Florida
-
SLR Credit Solutions Agents Senior Credit Facility for Velocity One
-
Nuclearn Unleashes Gamma2, The World's Largest AI Model Built for Nuclear
-
Winn-Dixie delivers summer meals and memories with $100,000 donation to Boys & Girls Clubs
-
Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases
-
Phare Bio Wins Newsweek’s AI Impact Award for “Most Innovative Technology or Service”
-
Neovera Adds Adversarial Fraud Control Testing with Acquisition of Greenway Solutions
-
Tech for Sustainability: Adastra Wins EUTECH SDG Award for Waste Monitoring Innovation
-
3D Systems Announces Issuance of $92 Million of Convertible Senior Secured Notes due 2030 and Retirement of $180 Million of Existing Convertible Senior Notes due 2026
-
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates
-
BPGbio Announces Presentation of Preliminary Clinical Data of Investigational BPM31510 for Primary CoQ10 Deficiency
-
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades
-
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Program at the 67th Annual Scientific Meeting of the American Headache Society (AHS)
-
Camunda Partners With rebuy to Automate and Orchestrate Device Repair Lifecycle
-
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
-
CIBC Innovation Banking Provides Growth Financing to Carefull to Accelerate Expansion
-
Extensive Greenland Lithium Exploration Campaign Launched by Brunswick Exploration
-
Gogo successfully completes first 5G end-to-end call.
-
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
-
HydroGraph Announces Kjirstin Breure as Board Chair
-
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Wee
-
Miguel Ángel Jiménez Signs with Newton Golf Company Following Tour Win Using Newton Fast Motion Shaft
-
Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia
-
Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from U.S. FDA and an ODD Positive Opinion from EMA for Treatment of Hereditary Hemorrhagic Telangiectas
-
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
-
Stillwater Critical Minerals Mobilizes Drill Rigs to Stillwater West Critical Minerals Project in Montana, USA
